74 related articles for article (PubMed ID: 1286747)
1. Control methods and thresholds of acceptability for antibrucella vaccines.
Bosseray N
Dev Biol Stand; 1992; 79():121-8. PubMed ID: 1286747
[TBL] [Abstract][Full Text] [Related]
2. Vaccination against bovine brucellosis with a low dose of strain 19 administered by the conjunctival route. I.--Protection demonstrated in guinea pigs.
Plommet M; Plommet AM
Ann Rech Vet; 1975; 6(4):345-56. PubMed ID: 821381
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against bovine brucellosis with a low dose of strain 19 administered by the conjunctival route. III. -- Serological response and immunity in the pregnant cow.
Plommet M; Fensterbank R
Ann Rech Vet; 1976; 7(1):9-23. PubMed ID: 984715
[TBL] [Abstract][Full Text] [Related]
4. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of antibrucellosis vaccines using guinea pigs].
Le Garrec Y; Pilet C; Garrido-Calderon N
Dev Biol Stand; 1976; 31():301-7. PubMed ID: 816686
[TBL] [Abstract][Full Text] [Related]
6. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
7. Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle.
Wyckoff JH; Howland JL; Scott CM; Smith RA; Confer AW
Vet Microbiol; 2005 Nov; 111(1-2):77-87. PubMed ID: 16242273
[TBL] [Abstract][Full Text] [Related]
8. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.
Olsen SC
Vet Ther; 2000; 1(3):183-91. PubMed ID: 19757581
[TBL] [Abstract][Full Text] [Related]
9. Vaccination of ewes by a single conjunctival administration of Brucella melitensis Rev. 1 vaccine.
Fensterbank R; Pardon P; Marly J
Ann Rech Vet; 1985; 16(4):351-6. PubMed ID: 4091489
[TBL] [Abstract][Full Text] [Related]
10. Venezuelan field trials of vaccines against brucellosis in swine.
Lord VR; Cherwonogrodzky JW; Schurig GG; Lord RD; Marcano MJ; Meléndez GE
Am J Vet Res; 1998 May; 59(5):546-51. PubMed ID: 9582954
[TBL] [Abstract][Full Text] [Related]
11. A recent trial comparing two 45/20 adjuvant Brucella vaccines.
McKeon FW
Dev Biol Stand; 1976; 31():343-50. PubMed ID: 816690
[TBL] [Abstract][Full Text] [Related]
12. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
Bolpe J; de Lapenta DF; García-Carrillo C
Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
[TBL] [Abstract][Full Text] [Related]
13. Conjunctival vaccination of young goats with Brucella melitensis strain Rev 1.
Fensterbank R; Verger JM; Grayon M
Ann Rech Vet; 1987; 18(4):397-403. PubMed ID: 3451685
[TBL] [Abstract][Full Text] [Related]
14. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
Dénes B
Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
[TBL] [Abstract][Full Text] [Related]
15. Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51.
Elzer PH; Enright FM; Colby L; Hagius SD; Walker JV; Fatemi MB; Kopec JD; Beal VC; Schurig GG
Am J Vet Res; 1998 Dec; 59(12):1575-8. PubMed ID: 9858409
[TBL] [Abstract][Full Text] [Related]
16. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
[TBL] [Abstract][Full Text] [Related]
17. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of strain RB51 vaccine in heifers against experimental brucellosis.
Poester FP; Gonçalves VS; Paixão TA; Santos RL; Olsen SC; Schurig GG; Lage AP
Vaccine; 2006 Jun; 24(25):5327-34. PubMed ID: 16713034
[TBL] [Abstract][Full Text] [Related]
19. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
